New Frontier Data

By William Sumner, Hemp Business Journal Contributor Last week, GW Pharmaceuticals (NASDAQ: GWPH) released its financial results for the second quarter, and the results surprised analysts and investors alike. Year-over-year, the company's revenue for the quarter rose from $3.3...

By Bill Griffin, Contributing Writer for New Frontier Data An adult arriving at Amsterdam Central Station could within minutes stroll into a nearby coffeeshop to purchase and consume some sparkling cannabis flowers to pair with their cappuccino. They would no doubt assume that recreational cannabis...

Growing a cannabis company takes capital – a lot of it. That's why we've been sharing some insights into what capital sources look for when providing financing to cannabis companies. In this two-part series, Andrew Lines, MAI, and a valuation partner at CohnReznick, talks with Paul...

  Q: For anyone who missed last week's webinar, "Are Your Numbers In Order? Preparing Your Cannabis Business for Turbulent Times Ahead", can you summarize what was shared? A: Though we have seen considerable growth and increased legitimacy in the legal cannabis industry, many...

By J.J. McCoy, Senior Managing Editor, New Frontier Data For the first time in five years of Colorado's coexisting, legalized adult-use and medical cannabis markets, recreational sales more than doubled medical sales in 2018, according to state regulators' figures. Colorado rolled out its...

By William Sumner, Hemp Business Journal Contributor As hemp companies and foreign investors seek new global markets for establishing operations, one region in particular resides relatively untapped. In terms of natural resources, Africa is one of the most abundant locales in the world, and...

By Bill Griffin, Contributing Writer for New Frontier Data Each member state in the European Union has their own distinct health systems. Combine that with the fact they all have their own laws regarding cannabis cultivation and distribution, the result is a smorgasbord of medical cannabis...

The post Potential Additional Annual Revenues From States Currently Debating New Cannabis Laws appeared first on New Frontier Data. Image Sourced From Pixabay

  Q: On your website, you refer to helping policymakers as well as investors and other industry stakeholders. What is an example of your involvement with government authorities?   A: Instances of how New Frontier Data engages with policymakers and regulators to help inform their...

By Hoban Law Group attorney, Patrick Goggin It's midsummer with California's State Assembly in recess, a great time to assess the state of hemp in the Golden State. Consistent with history, we find both progress and growing pains in the process. At the end of April, after much anticipation...

By Beau R Whitney, Vice President and Senior Economist, New Frontier Data A Florida court of appeals decision last month ruled that the state's regulatory framework for its medical cannabis program mandating vertical integration was unconstitutional. What does it mean for Florida's system,...

Research has demonstrated that the UK CBD market is a lot larger than original estimates. Reliable research commissioned by the London based Centre for Medicinal Cannabis puts a £300M ($375M) value on the current UK annual consumer spending. It is forecast that this market is growing in...

By Andrew R. Lines, MAI, Principal, CohnReznick The second in a series of CohnReznick interviews with companies working to address the cannabis industry's lack of traditional financing sources. Given the scarcity and high cost of capital for cannabis operators, Innovative Industrial Properties...

  In the most mature adult-use cannabis markets with medical cannabis programs (i.e., Colorado and Oregon), patient-saturation rates fell significantly once adult-use sales began. With long lags between legalizing medical cannabis programs and adult-use sales, both Colorado and Oregon saw...

By J.J. McCoy, Senior Managing Editor, New Frontier Data Medical cannabis patients tend to have enough concerns as it is, before any aggravation about the peculiarities of their particular state programs. Yet, it is an unavoidable condition for most patients and investors that they keep current...